United States · Series A startup

Who invested in Recros Medica

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$27Mraised across 3 rounds since 2017, from 3 sources

$9.0MRound$4.1MVenture$14MSeries A
Latest round
Series A, $14MNov 2019
Step-upi
3.4×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201720182019
$9.0MRound$4.1MVenture$14MSeries A
First round
Round, $9.0M
Jan 2017
Biggest round
$14M
Series A · Nov 2019
Usual gap between rounds
23 months
the median of 2

The rounds

  1. Nov 2019
    Series A$14M

    No investor was named in the report.

    Reported by FinSMEs

  2. Dec 2018
    Venture$4.1M1 returning

    Source recordedSEC filing: $4.1M sold, first sale Dec 2018

  3. Jan 2017
    Round$9.0M1 new

    Reported by FinSMEs

Everyone who backed them

Longwood FundVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Recros Medica

Who invested in Recros Medica?

Recros Medica's investors include Longwood Fund.

How much has Recros Medica raised?

Recros Medica has raised $27M across 3 rounds since 2017.

When did Recros Medica last raise?

Recros Medica's most recent round was a Series A of $14M in Nov 2019.

What was Recros Medica's biggest round?

Its most recent round, $14M in Nov 2019, is also its largest on record.

Who backed Recros Medica first?

Recros Medica's first round on record, in Jan 2017, was backed by Longwood Fund.

What stage is Recros Medica at?

Recros Medica's latest named round is a Series A, in Nov 2019.

Where is Recros Medica based?

Recros Medica is based in the United States.

Companies like Recros Medica

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.